Nexxen International Analysts Boost Their Forecasts After Upbeat Q1 Results

Benzinga

05/15

Nexxen International Ltd. (NASDAQ:NEXN) reported better-than-expected earnings for its first quarter on Wednesday.

The company posted quarterly earnings of 16 cents per share which beat the analyst consensus estimate of 5 cents per share. The company reported quarterly sales of $78.33 million which beat the analyst consensus estimate of $76.60 million.

「Our momentum continued in Q1 fueling record results driven by CTV, alongside significant Adjusted EBITDA growth,」 said Ofer Druker, Chief Executive Officer of Nexxen. 「We believe these results reflect the payoff from years of investment in our technology, data capabilities and brand. Industry partners are increasingly embracing our full stack of interconnected AI-powered data and technology solutions – driving greater spending, deeper adoption and long-term growth potential, even in uncertain market conditions.」

Nexxen shares fell 5.7% to close at $11.62 on Wednesday.

These analysts made changes to their price targets on Biodesix following earnings announcement.

Needham analyst Laura Martin maintained Nexxen International with a Buy and raised the price target from $12 to $14.
Rosenblatt analyst Barton Crockett maintained the stock with a Buy and raised the price target from $15 to $16.
JMP Securities analyst Matthew Condon maintained the stock with a Market Outperform and raised the price target from $11 to $15.

Considering buying CL stock? Here’s what analysts think:

Read This Next:

Jim Cramer: SoFi Goes To ‘New Highs,’ Recommends Not Buying This Health Care Stock

Photo via Shutterstock

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2535828837"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2535828837\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2535828837?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-15 20:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2535828837","market":"us","top_or_hot":-1,"title":"Nexxen International Analysts Boost Their Forecasts After Upbeat Q1 Results","media":"Benzinga","content":"<html><body><p><strong><a href=\"https://laohu8.com/S/NEXN\">Nexxen International</a> Ltd.</strong> (NASDAQ:NEXN) reported better-than-expected earnings for its first quarter on Wednesday.</p>\n<p>The company posted quarterly earnings of 16 cents per share which beat the analyst consensus estimate of 5 cents per share. The company reported quarterly sales of $78.33 million which beat the analyst consensus estimate of $76.60 million.</p>\n<p>「Our momentum continued in Q1 fueling record results driven by CTV, alongside significant Adjusted EBITDA growth,」 said Ofer Druker, Chief Executive Officer of Nexxen. 「We believe these results reflect the payoff from years of investment in our technology, data capabilities and brand. Industry partners are increasingly embracing our full stack of interconnected AI-powered data and technology solutions – driving greater spending, deeper adoption and long-term growth potential, even in uncertain market conditions.」</p>\n<p>Nexxen shares fell 5.7% to close at $11.62 on Wednesday.</p>\n<p>These analysts made changes to their price targets on Biodesix following earnings announcement.</p>\n<ul>\n<li>Needham analyst Laura Martin maintained Nexxen International with a Buy and raised the price target from $12 to $14.</li>\n<li>Rosenblatt analyst Barton Crockett maintained the stock with a Buy and raised the price target from $15 to $16.</li>\n<li>JMP Securities analyst Matthew Condon maintained the stock with a Market Outperform and raised the price target from $11 to $15.</li>\n</ul>\n<p><strong>Considering buying CL stock? Here’s what analysts think:</strong> </p>\n<figure><img decoding=\"async\" src=\"blob:https://editorial.benzinga.com/4011d15f-e260-4f74-87ae-27141197fbc9\"/></figure>\n<p><strong>Read This Next:</strong></p>\n<ul>\n<li><strong> Jim Cramer: SoFi Goes To ‘New Highs,’ Recommends Not Buying This Health Care Stock</strong> </li>\n</ul>\n<p>Photo via Shutterstock</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nexxen International Analysts Boost Their Forecasts After Upbeat Q1 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNexxen International Analysts Boost Their Forecasts After Upbeat Q1 Results\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2025-05-15 20:54</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<html><body><p><strong><a href=\"https://laohu8.com/S/NEXN\">Nexxen International</a> Ltd.</strong> (NASDAQ:NEXN) reported better-than-expected earnings for its first quarter on Wednesday.</p>\n<p>The company posted quarterly earnings of 16 cents per share which beat the analyst consensus estimate of 5 cents per share. The company reported quarterly sales of $78.33 million which beat the analyst consensus estimate of $76.60 million.</p>\n<p>「Our momentum continued in Q1 fueling record results driven by CTV, alongside significant Adjusted EBITDA growth,」 said Ofer Druker, Chief Executive Officer of Nexxen. 「We believe these results reflect the payoff from years of investment in our technology, data capabilities and brand. Industry partners are increasingly embracing our full stack of interconnected AI-powered data and technology solutions – driving greater spending, deeper adoption and long-term growth potential, even in uncertain market conditions.」</p>\n<p>Nexxen shares fell 5.7% to close at $11.62 on Wednesday.</p>\n<p>These analysts made changes to their price targets on Biodesix following earnings announcement.</p>\n<ul>\n<li>Needham analyst Laura Martin maintained Nexxen International with a Buy and raised the price target from $12 to $14.</li>\n<li>Rosenblatt analyst Barton Crockett maintained the stock with a Buy and raised the price target from $15 to $16.</li>\n<li>JMP Securities analyst Matthew Condon maintained the stock with a Market Outperform and raised the price target from $11 to $15.</li>\n</ul>\n<p><strong>Considering buying CL stock? Here’s what analysts think:</strong> </p>\n<figure><img decoding=\"async\" src=\"blob:https://editorial.benzinga.com/4011d15f-e260-4f74-87ae-27141197fbc9\"/></figure>\n<p><strong>Read This Next:</strong></p>\n<ul>\n<li><strong> Jim Cramer: SoFi Goes To ‘New Highs,’ Recommends Not Buying This Health Care Stock</strong> </li>\n</ul>\n<p>Photo via Shutterstock</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"次新股","start_time":0,"source_url":"https://www.benzinga.com/25/05/45435832/nexxen-international-analysts-boost-their-forecasts-after-upbeat-q1-results","article_id":"2535828837","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2535828837","pubTimestamp":1747313649,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":" ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4539":"次新股","NEXN":"Nexxen International","BK4009":"广告"},"translate_title":"耐克森国际分析师在第一季度业绩乐观后上调预测","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NEXN":0.9},"content_text":"Nexxen International Ltd. (NASDAQ:NEXN) reported better-than-expected earnings for its first quarter on Wednesday.\nThe company posted quarterly earnings of 16 cents per share which beat the analyst consensus estimate of 5 cents per share. The company reported quarterly sales of $78.33 million which beat the analyst consensus estimate of $76.60 million.\n「Our momentum continued in Q1 fueling record results driven by CTV, alongside significant Adjusted EBITDA growth,」 said Ofer Druker, Chief Executive Officer of Nexxen. 「We believe these results reflect the payoff from years of investment in our technology, data capabilities and brand. Industry partners are increasingly embracing our full stack of interconnected AI-powered data and technology solutions – driving greater spending, deeper adoption and long-term growth potential, even in uncertain market conditions.」\nNexxen shares fell 5.7% to close at $11.62 on Wednesday.\nThese analysts made changes to their price targets on Biodesix following earnings announcement.\n\nNeedham analyst Laura Martin maintained Nexxen International with a Buy and raised the price target from $12 to $14.\nRosenblatt analyst Barton Crockett maintained the stock with a Buy and raised the price target from $15 to $16.\nJMP Securities analyst Matthew Condon maintained the stock with a Market Outperform and raised the price target from $11 to $15.\n\nConsidering buying CL stock? Here’s what analysts think: \n\nRead This Next:\n\n Jim Cramer: SoFi Goes To ‘New Highs,’ Recommends Not Buying This Health Care Stock \n\nPhoto via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}